CLINICAL_TRIALS
trial_result
· 2024-05-31
Clinical Trial Update: A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 safety and efficacy study of CC-90009 in acute myeloid leukemia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: TERMINATED